Position in CADL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$421,476
+$82,837 QoQ
Shares Held
40,920
-40.8% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 138 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. CADL ranks #175 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in CADL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $421,476 | 40,920 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $338,639 | 69,110 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $390,471 | 69,110 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $352,461 | 69,110 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $349,696 | 69,110 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $60,229 | 10,660 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $92,528 | 10,660 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $73,873 | 10,660 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $66,092 | 10,660 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||